Treatment Modalities for Graves’ Ophthalmopathy: Systematic Review and Metaanalysis
نویسندگان
چکیده
منابع مشابه
Treatment modalities for Graves' ophthalmopathy: systematic review and metaanalysis.
BACKGROUND Graves' ophthalmopathy (GO) is a common cause of morbidity in patients with Graves' disease. Optimal treatment of GO remains unclear, and an evidence-based approach may improve patients' outcome. METHODS A systematic review and metaanalysis of randomized, controlled trials comparing treatment modalities for GO vs. placebo, no intervention, or other treatments. Primary outcome was t...
متن کاملThe pathogenesis and treatment of Graves' ophthalmopathy.
Graves' ophthalmopathy (GO) is probably an autoimmune condition although the pathogenesis is still not fully understood. GO is frequently, though not invariably, associated with Graves' disease and it may in fact be a separate disease entity. Ophthalmopathy is commonest in the 30 to 50 age group",2'3 and is more common in women (2:1, female:male), although the female preponderance is not so mar...
متن کاملA Systematic Review and Metaanalysis
2008;133;756-766 Chest Bradley S. Quon, Wen Qi Gan and Don D. Sin Review and Metaanalysis Exacerbations of COPD: A Systematic Contemporary Management of Acute http://chestjournal.org/cgi/content/abstract/133/3/756 and services can be found online on the World Wide Web at: The online version of this article, along with updated information ). ISSN: 0012-3692. http://www.chestjournal.org/misc/repr...
متن کاملGraves’ Ophthalmopathy
Copyright © 2009 Massachusetts Medical Society. A 40-year-old woman who recently received a diagnosis of Graves’ disease comes for a follow-up visit. She has been taking methimazole, at a dose of 10 mg daily, and is now euthyroid, but for the past 3 months, she has had bothersome eye symptoms, including redness, tearing, grittiness, photophobia, diplopia at the extremes of gaze, and ocular pain...
متن کاملEffect of octreotide treatment on Graves' ophthalmopathy.
In this study, nine patients with Graves' ophthalmopathy with positive clinical activity score (CAS), who were either unresponsive or not suitable for glucocorticoid treatment, were given 100 microg of octreotide three times daily, subcutaneously, for three months. The mean age was 49+/-13 years. All patients were under either propylthiouracil or methimazole therapy and were euthyroid for at le...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Journal of Clinical Endocrinology & Metabolism
سال: 2009
ISSN: 0021-972X,1945-7197
DOI: 10.1210/jc.2009-0376